Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors.
That, according to a person familiar with the matter, who spoke on condition of anonymity.
That would add a fourth dose to the regimen, which currently consists of a primary series of two shots, followed months later by a booster dose, in an effort to provide maximum protection to the over-65 population that has been hit hardest by the pandemic.
The Food and Drug Administration and the Centers for Disease Control must approve the request.
(Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.)
